Dr. David Maberley, MD, MSc. (Epid), FRCSC, Ophthalmologist, discusses macular degeneration risk factors and routine tests ...

For ophthalmologists, the weight-adjusted waist index could be a new tool for predicting age-related macular degeneration and intervention earlier.

New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon, explained ...

A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and ...

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

The primary driver of this market expansion is the rising demand for vitrectomy procedures, a critical surgical intervention for treating a range of eye conditions, particularly those affecting the ...

Imagine a world where lost vision could be restored. A new groundbreaking study might just turn this dream into reality, ...

Gold particles could help reproduce the visual signals of damaged photoreceptor cells and restore vision, according to new ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

We are observing this phenomenon from multiple perspectives: as a member of the New York City Council and Chair of the ...

Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...